InfuSystems HoldingsINFU +0.77%88 PB Ratio is 3.14 as of Jun. 25, 2026, which is 12% below its 10-year median of 3.56. GuruFocus rates INFU with a GF Score™ of 88/100 and a GF Value™ of $9.44 (Fairly Valued). The stock has 2 warning signs investors should review. Among 787 Medical Devices & Instruments companies, InfuSystems Holdings ranks worse than 66.2% on this metric.
The historical rank and industry rank for InfuSystems Holdings's PB Ratio or its related term are showing as below:
INFU'
s PB Ratio Range Over the Past 10 Years
Min: 0.59 Med: 3.56 Max: 13.08
Current: 3.14
During the past 13 years, InfuSystems Holdings's highest PB Ratio was 13.08. The lowest was 0.59. And the median was 3.56.
INFU's PB Ratio is ranked worse than 66.2% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.04
vs INFU: 3.14
During the past 12 months, InfuSystems Holdings's average Book Value Per Share Growth Rate was 10.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 7.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 6.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 5.70% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of InfuSystems Holdings was 30.70% per year. The lowest was -25.00% per year. And the median was 4.80% per year.
Back to Basics: PB Ratio
InfuSystems Holdings (AMEX:INFU) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
InfuSystems Holdings PB Ratio Related Terms
InfuSystems Holdings PB Ratio Historical Data
* Premium members only.
The historical data trend for InfuSystems Holdings's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, InfuSystems Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InfuSystems Holdings PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where InfuSystems Holdings's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
InfuSystems Holdings (INFU) has a PB Ratio of 3.14 as of Jun. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on InfuSystems Holdings and its competitors. This is 12% below median its historical median of 3.56. Over the past decade, InfuSystems Holdings' PB Ratio has ranged from 0.59 to 13.08. According to the industry distribution chart, InfuSystems Holdings ranks #521 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 66.2%.
Is InfuSystems Holdings' PB Ratio too high?
InfuSystems Holdings' current PB Ratio of 3.14 is 12% below median its 10-year median of 3.56. Over the past 10 years, this metric has ranged from a low of 0.59 to a high of 13.08. The Medical Devices & Instruments industry median PB Ratio is 2.04. InfuSystems Holdings' value of 3.14 is 53.9% above this industry median. Based on the distribution chart, InfuSystems Holdings ranks #521 out of 787 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, InfuSystems Holdings has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does InfuSystems Holdings' PB Ratio compare to TANAF and INGN?
According to the Medical Devices & Instruments industry distribution chart, InfuSystems Holdings ranks #521 out of 787 companies for PB Ratio. This places InfuSystems Holdings in the lower half of its industry. The industry median PB Ratio is 2.04. InfuSystems Holdings' value of 3.14 is 53.9% above this benchmark. Historically, InfuSystems Holdings' own PB Ratio has ranged from 0.59 to 13.08 over the past decade. While the company's 10-year median is 3.56 vs. the industry median of 2.04, InfuSystems Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.04, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InfuSystems Holdings's current PB Ratio of 3.14 is 53.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on InfuSystems Holdings and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InfuSystems Holdings's current PB Ratio is 3.14, which is 12% below median its own 10-year median of 3.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InfuSystems Holdings stock overvalued right now?
Based on GuruFocus' analysis, InfuSystems Holdings (INFU) is currently considered Fairly Valued. The stock's GF Value™ is $9.44, compared to a current price of $9.15 — trading 3.1% below its estimated fair value. The current PB Ratio is 3.14, which is 12% below median its 10-year median of 3.56 and 53.9% above the Medical Devices & Instruments industry median of 2.04. InfuSystems Holdings' overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For InfuSystems Holdings (INFU), the current PB Ratio is 3.14 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InfuSystems Holdings (INFU) Overvalued in 2026?
Based on GuruFocus' analysis, InfuSystems Holdings stock appears to be undervalued.
The current stock price of $9.15 is trading 3.1% below its estimated GF Value™ of $9.44.
GuruFocus considers InfuSystems Holdings to be Fairly Valued.
Key valuation signals for INFU:
PB Ratio: 3.14 (12% below median its 10-year median of 3.56)
GF Value™: $9.44 vs. price of $9.15 (3.1% below fair value)
Industry Position: 53.9% above the Medical Devices & Instruments median (#521 of 787)
No single metric tells the full story. See the INFU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
88GF Score
Get the complete analysis for INFU
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INFU has been successfully added to your 
